PUBLIC LAW 107-273—NOV. 2, 2002 116 STAT. 1793 SEC. 2103. MANDATORY REVOCATION OF PROBATION AND SUPER- VISED RELEASE FOR FAILING A DRUG TEST. (a) REVOCATION OF PROBATION.— Section 3565(b) of title 18, United States Code, is amended— (1) in paragraph (2), by striking "or" after the semicolon; (2) in paragraph (3), by striking "(4)," and inserting "(4); or"; and (3) by adding after paragraph (3) the following: "(4) as a part of drug testing, tests positive for illegal controlled substances more than 3 times over the course of 1 year;". (b) REVOCATION OF SUPERVISED RELEASE. —Section 3583(g) of title 18, United States Code, is amended— (1) in paragraph (2), by striking "or" after the semicolon; (2) in paragraph (3), by inserting "or" after the semicolon; and (3) by adding after paragraph (3) the following: "(4) as a part of drug testing, tests positive for illegal controlled substances more than 3 times over the course of 1 year;". Subtitle B—Treatment and Prevention SEC. 2201. REPORT ON DRUG-TESTING TECHNOLOGIES. (a) REQUIREMENT. —The National Institute of Justice shall conduct a study of drug-testing technologies in order to identify and assess the efticacy, accuracy, and usefulness for purposes of the National effort to detect the use of illicit drugs of any drug-testing technologies (including the testing of hair) that may be used as alternatives or complements to urinalysis as a means of detecting the use of such drugs. (b) REPORT. —Not later than 2 years after the date of enactment of this Act, the Institute shall submit to Congress a report on the results of the study conducted under subsection (a). SEC. 2202. DRUG AND SUBSTANCE ABUSE TREATMENT, PREVENTION, EDUCATION, AND RESEARCH STUDY. (a) IN GENERAL.—Not later than 180 days after the date of enactment of this Act, the President, after consultation with the Attorney General, Secretary of Health and Human Services, Secretary of Education, and other appropriate Federal officers, shall— (1) conduct a thorough review of all Federal drug and substance abuse treatment, prevention, education, and research programs; and (2) make such recommendations to Congress as the President may judge necessary and expedient to streamline, consolidate, coordinate, simplify, and more effectively conduct and deliver drug and substance abuse treatment, prevention, and education. (b) REPORT TO CONGRESS.— The report to Congress shall— (1) contain a survey of all Federal drug and substance abuse treatment, prevention, education, and research programs; (2) indicate the legal authority for each program, the amount of funding in the last 2 fiscal years for each program, and a brief description of the program; and 42 USC 3722 note. Deadline. Deadline.
�
